Keytruda sales power Merck to quarterly beat

Harvard, Merck Collaboration Aims to Discover New Immuno-oncology Targets

“This collaborative project aims to discover and validate novel regulators of immune responses,” said Dr. Sharpe. “Immunotherapies such as checkpoint inhibitors have revolutionized the treatment of cancer, but my lab is deeply interested in understanding why some patients do not respond or develop resistance to those interventions. My hope is that by defining mechanisms that[…]